CSIMarket
 
West Pharmaceutical Services Inc   (NYSE: WST)
 

West Pharmaceutical Services Inc's Customers Performance

WST



 
WST's Source of Revenues During the corresponding time, West Pharmaceutical Services Inc recorded a revenue increase by 13.89 % year on year, sequentially revenue grew by 3.3 %. While revenue at the West Pharmaceutical Services Inc 's corporate clients

List of WST Customers




for the same period West Pharmaceutical Services Inc recorded revenue increase by 13.89 % year on year, sequentially revenue grew by 3.3 %.

List of WST Customers

West Pharmaceutical Services Inc's Business Units
Proprietary Products    162.43 % of total Revenue
West Vantage    34.43 % of total Revenue






West Pharmaceutical Services Inc's Comment on Sales, Marketing and Customers



The company serves global biologic, generic, pharmaceutical, diagnostic, and medical device companies through two business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment provides elastomers, primary containment, drug delivery devices, integrated systems, and analytical laboratory services mainly to biologic, generic, and pharmaceutical customers. Its product offerings include stoppers, seals, syringe and cartridge components, administration systems, films, coatings, washing, vision inspection, sterilization services, vials, syringes, plungers, cartridges, and self-injection devices designed for at-home use. This segment also delivers integrated solutions such as analytical lab services, packaging support, engineering development, regulatory expertise, and after-sales technical support. The Contract-Manufactured Products segment specializes in the design, manufacture, and automated assembly of complex devices primarily for pharmaceutical, diagnostic, and medical device customers, providing custom contract manufacturing and assembly solutions.





West Pharmaceutical Services Inc’s Comment on Sales, Marketing and Customers


The company serves global biologic, generic, pharmaceutical, diagnostic, and medical device companies through two business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment provides elastomers, primary containment, drug delivery devices, integrated systems, and analytical laboratory services mainly to biologic, generic, and pharmaceutical customers. Its product offerings include stoppers, seals, syringe and cartridge components, administration systems, films, coatings, washing, vision inspection, sterilization services, vials, syringes, plungers, cartridges, and self-injection devices designed for at-home use. This segment also delivers integrated solutions such as analytical lab services, packaging support, engineering development, regulatory expertise, and after-sales technical support. The Contract-Manufactured Products segment specializes in the design, manufacture, and automated assembly of complex devices primarily for pharmaceutical, diagnostic, and medical device customers, providing custom contract manufacturing and assembly solutions.








WST's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
West Pharmaceutical Services Inc 23,900.12 3,220.50 542.70 10,800
SUBTOTAL 0.00 0.00 0.00 -

Sources: West Pharmaceutical Services Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: West Pharmaceutical Services Inc’s corporate clients.
For your research, we’ve provided 9 tables on West Pharmaceutical Services Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.